Mercer Global Advisors
CELU icon

Mercer Global Advisors’s Celularity CELU Stock Holding History

Mercer Global Advisors’s Portfolio CELU Stock Details CELU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$60 Buy
+100
New +$96 ﹤0.01% 5998

Other funds holding CELU

CVSC
C.V. Starr & Co New York $187M AUM 26.03% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
HWM
HB Wealth Management Atlanta, Georgia $17.8B AUM 24.16% 1-Year Est. Return
KFS
Keynote Financial Services Vernon, Connecticut $214M AUM 60.12% 1-Year Est. Return
CAM
CenterStar Asset Management Chicago, Illinois $589M AUM 34.51% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

Mercer Global Advisors's CELU Position: Q2 2026 in Review

Mercer Global Advisors opened a new position in Celularity (CELU) in Q2 2026: 100 shares worth $60. The stake represents ﹤0.01% of the portfolio and ranks #5998 among its holdings.

20 funds tracked by Wall St. Rank hold CELU as of Q2 2026.

  • Mercer Global Advisors held 100 shares of Celularity worth $60 as of Q2 2026.
  • Celularity was a new Mercer Global Advisors position in Q2 2026.
  • Celularity made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #5998 holding.
  • 20 funds tracked by Wall St. Rank held Celularity as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.